Provectus Biopharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Provectus Biopharmaceuticals's estimated annual revenue is currently $1.6M per year.
- Provectus Biopharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- Provectus Biopharmaceuticals has 10 Employees.
- Provectus Biopharmaceuticals grew their employee count by -17% last year.
Provectus Biopharmaceuticals's People
| Name | Title | Email/Phone |
|---|
Provectus Biopharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.9M | 12 | 9% | N/A | N/A |
#2 | $6M | 39 | 15% | N/A | N/A |
#3 | $5.1M | 33 | 43% | N/A | N/A |
#4 | $1.4M | 9 | -18% | N/A | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $0.8M | 5 | 0% | N/A | N/A |
#7 | $10.2M | 66 | 69% | N/A | N/A |
#8 | $1.1M | 7 | 17% | N/A | N/A |
#9 | $5M | 32 | 3% | N/A | N/A |
#10 | $1.7M | 11 | -8% | N/A | N/A |
What Is Provectus Biopharmaceuticals?
Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers.
keywords:N/A
N/A
Total Funding
10
Number of Employees
$1.6M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Knoxville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.9M | 10 | 0% | N/A |
#2 | $0.9M | 10 | 67% | N/A |
#3 | $0.8M | 10 | N/A | N/A |
#4 | $0.9M | 10 | 25% | N/A |
#5 | $0.9M | 10 | -17% | N/A |